These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27618679)

  • 1. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
    Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
    J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimigratory effect of TK1-2 is mediated in part by interfering with integrin alpha2beta1.
    Kim HK; Oh DS; Lee SB; Ha JM; Joe YA
    Mol Cancer Ther; 2008 Jul; 7(7):2133-41. PubMed ID: 18645023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kringle domain of tissue-type plasminogen activator inhibits extracellular matrix-induced adhesion and migration of endothelial cells.
    Lee BH; Kim HK; Joe YA
    Biosci Biotechnol Biochem; 2008 Sep; 72(9):2303-8. PubMed ID: 18776698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
    Kim HK; Joe YA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
    Sulochana KN; Fan H; Jois S; Subramanian V; Sun F; Kini RM; Ge R
    J Biol Chem; 2005 Jul; 280(30):27935-48. PubMed ID: 15923192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
    Lee SB; Oh HK; Kim HK; Joe YA
    Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
    Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
    Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
    Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
    Sun Y; Su L; Wang Z; Xu Y; Xu X
    BMC Cell Biol; 2013 Feb; 14():8. PubMed ID: 23433118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
    Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A C-terminal fragment BIGH3 protein with an RGDRGD motif inhibits corneal neovascularization in vitro and in vivo.
    Ge H; Tian P; Guan L; Yin X; Liu H; Xiao N; Xiong Y; Luo X; Sun Y; Qi D; Ni S; Liu P
    Exp Eye Res; 2013 Jul; 112():10-20. PubMed ID: 23562678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
    Wang Z; Zhao H; Ma JX; Xu X
    Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
    Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization.
    Lee JE; Kim KL; Kim D; Yeo Y; Han H; Kim MG; Kim SH; Kim H; Jeong JH; Suh W
    Int J Nanomedicine; 2017; 12():4813-4822. PubMed ID: 28740387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.